Drug recall · July 12, 2017
Amitriptyline HCl Tablets recall
Why: Cross Contamination With Other Product: Imipramine
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Amitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01) and b) 1000-count bottles ( NDC 0781-1487-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540
- Lots / codes
Lot #: a) GR3831, GS9690, Exp. 08/2019; b) GR3832, Exp. 08/2019.
- Quantity
- 38,234 bottles
- Company
- Sandoz Incorporated, Broomfield, CO
- Distribution
- Product was distributed throughout the United States
- Initiated
- June 16, 2017 · Voluntary: Firm initiated
- Classified
- July 6, 2017
- Reported
- July 12, 2017
- Ended
- January 14, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amitriptyline
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.